These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 11129571

  • 1. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants.
    Shiota N, Kodama S, Inui H, Ohkawa H.
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571
    [Abstract] [Full Text] [Related]

  • 2. Herbicide-resistant tobacco plants expressing the fused enzyme between rat cytochrome P4501A1 (CYP1A1) and yeast NADPH-cytochrome P450 oxidoreductase.
    Shiota N, Nagasawa A, Sakaki T, Yabusaki Y, Ohkawa H.
    Plant Physiol; 1994 Sep; 106(1):17-23. PubMed ID: 7972515
    [Abstract] [Full Text] [Related]

  • 3. Biotransformation of atrazine in transgenic tobacco cell culture expressing human P450.
    Bode M, Stöbe P, Thiede B, Schuphan I, Schmidt B.
    Pest Manag Sci; 2004 Jan; 60(1):49-58. PubMed ID: 14727741
    [Abstract] [Full Text] [Related]

  • 4. Biotransformation of metamitron by human p450 expressed in transgenic tobacco cell cultures.
    Bode M, Haas M, Faymonville T, Thiede B, Schuphan I, Schmidt B.
    J Environ Sci Health B; 2006 Jan; 41(3):201-22. PubMed ID: 16484082
    [Abstract] [Full Text] [Related]

  • 5. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M, Carreira F, Theisen P, Laires A, Fisher CW, Rueff J, Estabrook RW, Vermeulen NP.
    Mutat Res; 1999 Apr 26; 441(1):73-83. PubMed ID: 10224324
    [Abstract] [Full Text] [Related]

  • 6. Functional expression of fused enzymes between human cytochrome P4501A1 and human NADPH-cytochrome P450 oxidoreductase in Saccharomyces cerevisiae.
    Wittekindt NE, Würgler FE, Sengstag C.
    DNA Cell Biol; 1995 Apr 26; 14(4):273-83. PubMed ID: 7710684
    [Abstract] [Full Text] [Related]

  • 7. Herbicide resistance of transgenic rice plants expressing human CYP1A1.
    Kawahigashi H, Hirose S, Ohkawa H, Ohkawa Y.
    Biotechnol Adv; 2007 Apr 26; 25(1):75-84. PubMed ID: 17156966
    [Abstract] [Full Text] [Related]

  • 8. Molecular cloning and expression in Saccharomyces cerevisiae of tobacco NADPH-cytochrome P450 oxidoreductase cDNA.
    Yamada T, Imaishi H, Oka A, Ohkawa H.
    Biosci Biotechnol Biochem; 1998 Jul 26; 62(7):1403-11. PubMed ID: 9720224
    [Abstract] [Full Text] [Related]

  • 9. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T, Gillam EM, Sutter TR, Strickland PT, Guengerich FP, Yamazaki H.
    Drug Metab Dispos; 1997 May 26; 25(5):617-22. PubMed ID: 9152602
    [Abstract] [Full Text] [Related]

  • 10. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
    Sengstag C, Eugster HP, Würgler FE.
    Carcinogenesis; 1994 May 26; 15(5):837-43. PubMed ID: 8200084
    [Abstract] [Full Text] [Related]

  • 11. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
    Arlt VM, Levová K, Bárta F, Shi Z, Evans JD, Frei E, Schmeiser HH, Nebert DW, Phillips DH, Stiborová M.
    Chem Res Toxicol; 2011 Oct 17; 24(10):1710-9. PubMed ID: 21932800
    [Abstract] [Full Text] [Related]

  • 12. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
    Parikh A, Guengerich FP.
    Protein Expr Purif; 1997 Apr 17; 9(3):346-54. PubMed ID: 9126606
    [Abstract] [Full Text] [Related]

  • 13. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen.
    Stiborová M, Sopko B, Hodek P, Frei E, Schmeiser HH, Hudecek J.
    Cancer Lett; 2005 Nov 18; 229(2):193-204. PubMed ID: 16125300
    [Abstract] [Full Text] [Related]

  • 14. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
    Ohgiya S, Goda T, Hoshino T, Kamataki T, Ishizaki K.
    Arch Biochem Biophys; 1997 Jul 15; 343(2):215-24. PubMed ID: 9224733
    [Abstract] [Full Text] [Related]

  • 15. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
    Stiborová M, Frei E, Wiessler M, Schmeiser HH.
    Chem Res Toxicol; 2001 Aug 15; 14(8):1128-37. PubMed ID: 11511187
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of detergents on rat CYP1A1-dependent monooxygenase: comparison of mixed and fused systems consisting of rat CYP 1A1 and yeast NADPH-P450 reductase.
    Inouye K, Kondo S, Yamamura M, Nakanishi D, Sakaki T.
    Biochem Biophys Res Commun; 2001 Feb 09; 280(5):1346-51. PubMed ID: 11162677
    [Abstract] [Full Text] [Related]

  • 17. Transgenic rice plants expressing human CYP1A1 remediate the triazine herbicides atrazine and simazine.
    Kawahigashi H, Hirose S, Ohkawa H, Ohkawa Y.
    J Agric Food Chem; 2005 Nov 02; 53(22):8557-64. PubMed ID: 16248553
    [Abstract] [Full Text] [Related]

  • 18. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ, Kim MY, Guengerich FP.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):20-4. PubMed ID: 10448061
    [Abstract] [Full Text] [Related]

  • 19. Electrostatic interaction between cytochrome P450 and NADPH-P450 reductase: comparison of mixed and fused systems consisting of rat cytochrome P450 1A1 and yeast NADPH-P450 reductase.
    Kondo S, Sakaki T, Ohkawa H, Inouye K.
    Biochem Biophys Res Commun; 1999 Apr 13; 257(2):273-8. PubMed ID: 10198202
    [Abstract] [Full Text] [Related]

  • 20. Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model.
    Levová K, Moserová M, Kotrbová V, Sulc M, Henderson CJ, Wolf CR, Phillips DH, Frei E, Schmeiser HH, Mares J, Arlt VM, Stiborová M.
    Toxicol Sci; 2011 May 13; 121(1):43-56. PubMed ID: 21362632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.